BMJ partners with Chinese Stroke Association on new open-access journal

November 06, 2015

Global healthcare knowledge provider BMJ has partnered with the Chinese Stroke Association to produce a new open access journal, Stroke and Vascular Neurology, the company has announced.

The journal, which represents BMJ's first joint publishing venture in the People's Republic of China, will be owned by the Chinese Stroke Association (CSA), but published by BMJ.

Stroke and Vascular Neurology will officially launch in February 2016, with Professor Yongjun Wang, of Tiantan Hospital in Beijing, as its editor in chief.

Stroke and Vascular Neurology will be the official journal of the CSA, one of China's leading professional medical organisations. It will have a global focus, facilitated by an international editorial board, drawing on expertise from Asia, Australia, Europe, and North America.

As such, it aims to become the leading peer reviewed journal for clinical stroke neurologists, neurosurgeons, neurointerventionists, neurointensivists, those interested in inpatient neurological care (neurohospitalists), and basic neuroscientists worldwide.

Content will include original clinical and translational research, brief reports, protocols, interesting case studies, review articles and editorials. And the journal welcomes debate on controversial techniques, health policy, and social medicine.

But key criteria for acceptance will be ethical and methodological rigour rather than novelty or relevance to any particular group.

Stroke and Vascular Neurology will issue quarterly, with the bulk of its content published in English. In common with BMJ's other open access titles, it will operate a fast submission and review process, with continuous publication online, ensuring that up to date high quality research is rapidly available worldwide.

Stroke and Vascular Neurology will join BMJ's extensive stable of specialist journals, which include the Journal of Neurology Neurosurgery and Psychiatry, Practical Neurology, and the Journal of NeuroInterventional Surgery.

"The launch of Stroke and Vascular Neurology is a major development for BMJ and we're delighted and honoured that the Chinese Stroke Association have selected BMJ as their partner," comments BMJ Publishing Director Peter Ashman.

"Following the opening of our office in Beijing, we see this partnership as an endorsement of BMJ's credentials as an important healthcare knowledge provider in China, whilst we can offer CSA the benefits of our reach and relationship as an integral part of the international medical community," he adds.

Editor in chief, Professor Yongjun Wang, said: "It's our pleasure to cooperate with BMJ on this high quality journal. Stroke and Vascular Neurology will be the official English Journal for CSA and we aim not only to showcase the sophisticated research in stroke all over the world, but also to provide a platform for exchange among the excellent experts and scholars worldwide."

He adds: "The journey may be long but the future is full of hope. We will work together to reduce stroke mortality, disability and its financial burden in China and the world."
About BMJ

BMJ is a healthcare knowledge provider that aims to advance healthcare worldwide by sharing knowledge and expertise to improve experiences, outcomes and value. A full list of BMJ products and services is available here:

About CSA

Chinese Stroke Association (CSA) is an academic nonprofit professional organization dedicated to stroke prevention, therapy, rehabilitation, research, quality of care and education:


Related Stroke Articles from Brightsurf:

Stroke alarm clock may streamline and accelerate time-sensitive acute stroke care
An interactive, digital alarm clock may speed emergency stroke care, starting at hospital arrival and through each step of the time-sensitive treatment process.

Stroke patients with COVID-19 have increased inflammation, stroke severity and death
Stroke patients who also have COVID-19 showed increased systemic inflammation, a more serious stroke severity and a much higher rate of death, compared to stroke patients who did not have COVID-19, according a retrospective, observational, cross-sectional study of 60 ischemic stroke patients admitted to UAB Hospital between late March and early May 2020.

'Time is vision' after a stroke
University of Rochester researchers studied stroke patients who experienced vision loss and found that the patients retained some visual abilities immediately after the stroke but these abilities diminished gradually and eventually disappeared permanently after approximately six months.

More stroke awareness, better eating habits may help reduce stroke risk for young adult African-Americans
Young African-Americans are experiencing higher rates of stroke because of health conditions such as high blood pressure, diabetes and obesity, yet their perception of their stroke risk is low.

How to help patients recover after a stroke
The existing approach to brain stimulation for rehabilitation after a stroke does not take into account the diversity of lesions and the individual characteristics of patients' brains.

Kids with headache after stroke might be at risk for another stroke
A new study has found a high incidence of headaches in pediatric stroke survivors and identified a possible association between post-stroke headache and stroke recurrence.

High stroke impact in low- and middle-income countries examined at 11th World Stroke Congress
Less wealthy countries struggle to meet greater need with far fewer resources.

Marijuana use might lead to higher risk of stroke, World Stroke Congress to be told
A five-year study of hospital statistics from the United States shows that the incidence of stroke has risen steadily among marijuana users even though the overall rate of stroke remained constant over the same period.

We need to talk about sexuality after stroke
Stroke survivors and their partners are not adequately supported to deal with changes to their relationships, self-identity, gender roles and intimacy following stroke, according to new research from the University of Sydney.

Standardized stroke protocol can ensure ELVO stroke patients are treated within 60 minutes
A new study shows that developing a standardized stroke protocol of having neurointerventional teams meet suspected emergent large vessel occlusion (ELVO) stroke patients upon their arrival at the hospital achieves a median door-to-recanalization time of less than 60 minutes.

Read More: Stroke News and Stroke Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to